Dr. Cook-Bolden is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
258 St. Nicholas Avenue
New York, NY 10027Phone+1 914-246-0003
Summary
- Dr. Fran Cook-Bolden is a dermatologist in New York City (Manhattan), Westchester County and Bronx, NY and is Clinical Assistant Professor of Dermatology at Weill Cornell and is affiliated with Mount Sinai Beth Israel. Her research division is in Bronx, NY. She received her medical degree from Howard University College of Medicine and has been in practice 30 years. She has completed training in Combined Internal Medicine and Pediatrics, in addition to Medical and Cosmetic and Laser Dermatology and Dermatologic Surgery. She has been a Research Principal Investigator for over 25 years and is experienced in general dermatology, skin of color, hair loss treatment, pigmentation disorders, skin cancer treatment, acne and rosacea, atopic dermatitis, psoriasis and other dermatitis, dermatologic surgery, cosmetic dermatology, and laser surgery.
Education & Training
- New York Medical College (Metropolitan)Residency, Dermatology, 1992 - 1996
- SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 1988 - 1990
- Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalInternship, Internal Medicine/Pediatrics, 1987 - 1988
- Howard University College of MedicineClass of 1987
Certifications & Licensure
- NY State Medical License 1990 - 2026
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2014-2019
- CMS Meaningful Use Stage 1 Certification athenaClinicals EHR, athenahealth, Inc, 2013
- Fellow (FASDS) American Society for Dermatologic Surgery
Clinical Trials
- A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis Start of enrollment: 2013 Nov 01
- A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26) Start of enrollment: 2015 Nov 16
Publications & Presentations
PubMed
- 31 citationsGuidelines of care for the management of acne vulgaris.Rachel V Reynolds, Howa Yeung, Carol E Cheng, Fran Cook-Bolden, Seemal R Desai
Journal of the American Academy of Dermatology. 2024-05-01 - 2 citationsImprovements in acne and skin oiliness with tazarotene 0.045% lotion in patients with oily skin.Emil A Tanghetti, Joshua A Zeichner, Michael Gold, Neil Sadick, Fran E Cook-Bolden
The Journal of Dermatological Treatment. 2023-12-01 - Influence of Season on Efficacy and Tolerability of Tazarotene 0.045% Lotion for the Treatment of Acne.Jerry Tan, Zoe D Draelos, Melinda J Gooderham, Andrew F Alexis, Emmy Graber
The Journal of Clinical and Aesthetic Dermatology. 2023-09-01
Press Mentions
- Vitamins for Nails: Do Nail Growth Supplements Work? We Asked the DoctorsDecember 10th, 2019
- What Causes Excessive Sweating?November 18th, 2019
- Are Those Watermelon Infused Skincare Products Worth Your Coins?August 5th, 2019
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: